# Trade Mark Journal No.2026/029 17 July 2026

## UK00004381219 30 April 2026 (40,42)

Class 40
  Providing information relating to material treatment; custom assembling of materials for others; Custom manufacture of pharmaceuticals; Custom Drug Manufacturing Using Biomanufacturing Technology; Custom manufacture of biopharmaceuticals; Custom Pharmaceutical Manufacturing Services; Custom Biologics Manufacturing Services; Custom Manufacturing of Dietary Supplements for Human Use; Chemical reagent processing and treatment; Processing of Biopharmaceutical Preparations.
Class 42
  Research and development of new products; scientific research and development; chemical research services; biochemical research and analysis; culturing of cells for scientific research purposes; genome structure and function analysis; pharmaceutical drug evaluation; Conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical formulations and drugs; Research and development in the field of antibodies; Pharmaceutical drug development services; research on bioconjugates; development of bioconjugates; Testing of pharmaceuticals.

BIODLINK BIOPHARM CO., LTD.

Representative: Barker Brettell LLP